Apr 11, 2020

CREBBP/EP300 mutation is associated with poor outcome in HNSCC and targetable with synthetic cytotoxicity.

BioRxiv : the Preprint Server for Biology
M. KumarHeath D Skinner


Background: Head and neck squamous cell carcinoma (HNSCC) harbors few directly targetable mutations, however several mutations in this malignancy may be sensitive to synthetic cytotoxicity. Methods: Whole exome sequencing in human HNSCC tumors (n=235) was analyzed for effect on outcome. In vivo shRNA screening in HNSCC models was performed following by in vitro and in vivo studies of tumor response and DNA damage repair. Results: Mutation in either the histone acetyltransferases CREBBP and EP300 or CASP8 were associated with poor outcome following radiation therapy in HNSCC. In vivo shRNA screening identified synthetic cytotoxicity in CREBBP/EP300 mutant tumors by combining radiation and inhibition of histone acetyltransferase (HAT) function. This effect appears to be due to increased DNA damage following ionizing radiation through inhibition of homologous recombination and altered acetylation of histone marks. Conclusion: CREBBP/EP300 mutation is associated with radiation resistance in HNSCC and is targetable via synthetic cytotoxicity.

  • References
  • Citations


  • We're still populating references for this paper, please check back later.
  • References
  • Citations


  • This paper may not have been cited yet.

Mentioned in this Paper

Gene Deletion
Nucleic Acid Sequencing
Nuclear Translocation
Chromosomal Structural Abnormalities

Related Feeds

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.

Related Papers

The Veterinary Journal
Wachiraphan SupsavhadThomas J Rosol
Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
X J YanX X Zhang
© 2020 Meta ULC. All rights reserved